Trial · NCT07902882
A Clinical Trial to Examine the Effects of Gut Health Supplements to Improve Gut and Digestive Health and Function
NCT07902882, Not applicable, Completed, JS Health & Vitamins
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Clinical Trial to Examine the Effects of Gut Health Supplements to Improve Gut and Digestive Health and Function. Trials, record NCT07902882. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902882
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Clinical Trial to Examine the Effects of Gut Health Supplements to Improve Gut and Digestive Health and Function
- NCT number
- NCT07902882
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 60 participants, actual
- Lead sponsor
- JS Health & Vitamins
- Conditions
- Bloating, Digestive Discomfort, Irritable Bowel Syndrome (IBS), Flatulence, Constipation, Gut Health
- Interventions
- Intervention, Placebo
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in digestive and gut health symptoms including reduced stomach bloating and fluid retention | Baseline, Day 1 (after first use), Week 2, and Week 4 | Assessed via study-specific self-reported questionnaires measuring perceived reduction in stomach bloating and fluid retention |
| Primary | Change in relief from symptoms of IBS | Baseline, Day 1 (after first use), Week 2, and Week 4 | Assessed via study-specific self-reported questionnaires measuring relief from IBS symptoms, flatulence, and digestive discomfort |
| Primary | Change in relief from symptoms of flatulence | Baseline, Day 1 (after first use), Week 2, and Week 4 | Assessed via study-specific self-reported questionnaires measuring relief from IBS symptoms, flatulence, and digestive discomfort |
| Primary | Change in relief from symptoms of digestive discomfort | Baseline, Day 1 (after first use), Week 2, and Week 4 | Assessed via study-specific self-reported questionnaires measuring relief from IBS symptoms, flatulence, and digestive discomfort |
| Primary | Time to symptom relief | Baseline, Day 1 (after first use), Week 2, and Week 4 | Assessed via study-specific self-reported questionnaires measuring time to onset of digestive symptom relief |
| Primary | Change in abdominal circumference | Baseline, Week 2, Week 4, Week 6, and Week 8 | At-home independent waist/abdominal circumference measurement using a provided tape measure |
| Secondary | Change in bloating and IBS symptoms with combination supplementation | Baseline, Week 6, and Week 8 | Assessed via study-specific self-reported questionnaires measuring noticeably less bloating and IBS symptoms when Debloat \& Detox is used in combination with the Probiotic supplement |
| Secondary | Change in relief from constipation | Baseline, Week 6, and Week 8 | Assessed via study-specific self-reported questionnaires measuring relief from constipation when using both supplements in combination |
| Secondary | Change in overall gut and digestive function | Baseline, Week 6, and Week 8 | Assessed via study-specific self-reported questionnaires measuring overall improvement in gut and digestive function with combination supplementation |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902882
GET https://conductscience.org/api/trials/v1/NCT07902882/registered